The US Approves the World’s First Vaccine for Honeybees for Conditional Use
The importance of bees to mankind is beyond measure. Their pollination activity generates food for all. So it is imperative to take measures to stop the decline in the bee population. Earlier this week, a biotech company said that the USDA (Department of Agriculture) had given them a conditional license for their honeybee vaccine. The vaccination strengthens the bee's immune system to combat American foulbrood disease, a bacterial infection that is brought on by Paenibacillus larvae and is known to harm colonies. Until now, the only option for treating the highly contagious illness was to burn the bees, the contaminated hives, and all the associated equipment. When all the worker bees have consumed the vaccine, it is then absorbed into the royal jelly, which is fed to the queen. Fragments of the vaccine are deposited in her ovaries when she consumes it. The growing larvae have immunity when they hatch because they have been exposed to the vaccination. Dr. Annette Kleiser, CEO of Dalan Animal Health said in a statement that their vaccine is a breakthrough in protecting honeybees, impacting food production on a global scale. Trevor Tauzer, owner of Tauzer Apiaries and board member of the California Beekeepers Association remarked that this was an exciting step forward for beekeepers as they had to rely on antibiotic treatment that had limited effectiveness and required lots of time and energy to apply to the hives.